UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 239

Sortiert nach

How I treat the acquired von Willebrand syndrome

Blood, 2011-06, Vol.117 (25), p.6777-6785

2011

Link zum Volltext

Verfügbarkeit prüfen

Textbook of Von Willebrand Disease: Basic and Clinical Aspects

2, 2024

Link zum Volltext

Verfügbarkeit prüfen

Activation-independent platelet adhesion and aggregation under elevated shear stress

Blood, 2006-09, Vol.108 (6), p.1903-1910

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical and laboratory diagnosis of VWD

Hematology, 2014-12, Vol.2014 (1), p.524-530

Federici, Augusto B

2014

Link zum Volltext

Verfügbarkeit prüfen

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

Blood, 2013-03, Vol.121 (12), p.2336-2339

2013

Link zum Volltext

Verfügbarkeit prüfen

An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets

Blood, 2011-11, Vol.118 (20), p.5641-5651

2011

Link zum Volltext

Verfügbarkeit prüfen

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

American journal of obstetrics and gynecology, 2009-07, Vol.201 (1), p.12.e1-12.e8

2009

Link zum Volltext

Verfügbarkeit prüfen

HDL/ApoA-I: role in VWF-dependent thrombosis

Blood, 2016-02, Vol.127 (5), p.526-528

Federici, Augusto B.

2016

Link zum Volltext

Verfügbarkeit prüfen

Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality

Seminars in thrombosis and hemostasis, 2016-07, Vol.42 (5), p.478

2016

Link zum Volltext

Verfügbarkeit prüfen

Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update

Seminars in thrombosis and hemostasis, 2013-03, Vol.39 (2), p.191

2013

Link zum Volltext

Verfügbarkeit prüfen

The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD

British journal of haematology, 2010-11, Vol.151 (3), p.245-251

2010

Link zum Volltext

Verfügbarkeit prüfen

Towards a more automatic and rapid laboratory diagnosis of von Willebrand disease

Thrombosis research, 2016-05, Vol.141, p.198-201

Federici, Augusto B

2016

Link zum Volltext

Verfügbarkeit prüfen

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Blood, 2014-06, Vol.123 (26), p.4037-4044

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

Transfusion, 2014-07, Vol.54 (7), p.1756-1768

2014

Link zum Volltext

Verfügbarkeit prüfen

A need to increase von Willebrand disease awareness: vwdtest.com – A global initiative to help address this gap

Blood reviews, 2023-03, Vol.58, p.101018-101018, Article 101018

2023

Link zum Volltext

Verfügbarkeit prüfen

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

Blood transfusion = Trasfusione del sangue, 2019-05, Vol.17 (3), p.171-180

2019

Link zum Volltext

Verfügbarkeit prüfen

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

Blood, 2004-10, Vol.104 (8), p.2359-2367

2004

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

Blood, 2009-01, Vol.113 (3), p.526-534

2009

Link zum Volltext

Verfügbarkeit prüfen

Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry

British journal of haematology, 2019-03, Vol.184 (5), p.853-855

2019

Link zum Volltext

Verfügbarkeit prüfen

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel

European journal of haematology, 2022-08, Vol.109 (2), p.121-128

2022

Link zum Volltext

Verfügbarkeit prüfen

Contemporary issues in the management of von Willebrand disease

Thrombosis and haemostasis, 2016, Vol.116 Suppl 1, p.S18

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease

Blood transfusion = Trasfusione del sangue, 2019-09, Vol.17 (5), p.391-398

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients

Blood cells, molecules, & diseases, 2003-05, Vol.30 (3), p.264-270

2003

Link zum Volltext

Verfügbarkeit prüfen

von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Journal of thrombosis and haemostasis, 2023-04, Vol.21 (4), p.787-799

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 239

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(212)

Publikationsform

Sprache

Englisch
(239)
Japanisch
(14)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(121)
Science & Technology
(98)
Life Sciences & Biomedicine
(97)
Hematology
(88)
Von Willebrand Factor
(69)
Biological And Medical Sciences
(61)
Medical Sciences
(57)
Von Willebrand Disease
(57)
Female
(44)
Hematologic And Hematopoietic Diseases
(44)
Male
(40)
Platelet Diseases And Coagulopathies
(37)
Von Willebrand Diseases - Diagnosis
(36)
Adult
(28)
Von Willebrand Factor - Metabolism
(28)
Von Willebrand Diseases - Genetics
(26)
Middle Aged
(25)
Von Willebrand Diseases - Therapy
(24)
Von Willebrand Diseases - Drug Therapy
(23)
Adolescent
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

How I treat the acquired von Willebrand syndrome

Textbook of Von Willebrand Disease: Basic and Clinical Aspects

Activation-independent platelet adhesion and aggregation under elevated shear stress

Clinical and laboratory diagnosis of VWD

VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

An intact PDZ motif is essential for correct P2Y12 purinoceptor traffic in human platelets

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

HDL/ApoA-I: role in VWF-dependent thrombosis

Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality

Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update

The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD

Towards a more automatic and rapid laboratory diagnosis of von Willebrand disease

The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease

Evaluation and management of postpartum hemorrhage: consensus from an international expert panel

A need to increase von Willebrand disease awareness: vwdtest.com – A global initiative to help address this gap

Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus

An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

Activated prothrombin complex concentrate (FEIBA®) in acquired haemophilia A: a large multicentre Italian study – the FAIR Registry

Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long‐term prophylaxis: An expert opinion paper from an Italian panel

Contemporary issues in the management of von Willebrand disease

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease

Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients

von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Suchergebnisse filtern